Transfusion of Blood and Blood Products

[1]  J. Holcomb,et al.  Emergency department blood transfusion predicts early massive transfusion and early blood component requirement , 2010, Transfusion.

[2]  H. Alter,et al.  Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples , 2010, Transfusion.

[3]  K. Davis,et al.  The status of massive transfusion protocols in United States trauma centers: massive transfusion or massive confusion? , 2010, Transfusion.

[4]  R. Cable,et al.  Direct assessment of cytomegalovirus transfusion‐transmitted risks after universal leukoreduction , 2010, Transfusion.

[5]  D. Wisner,et al.  Should we increase the ratio of plasma/platelets to red blood cells in massive transfusion: what is the evidence? , 2010, Vox sanguinis.

[6]  E. Vamvakas,et al.  Blood Still Kills: Six Strategies to Further Reduce Allogeneic Blood Transfusion-Related Mortality , 2010, Transfusion Medicine Reviews.

[7]  C. Guerriero,et al.  The risk of transfusion‐transmitted infections in sub‐Saharan Africa , 2010, Transfusion.

[8]  N. Burton,et al.  A new blood group system, RHAG: three antigens resulting from amino acid substitutions in the Rh‐associated glycoprotein , 2010, Vox sanguinis.

[9]  S. Kleinman,et al.  Emerging infectious disease agents and their potential threat to transfusion safety , 2009, Transfusion.

[10]  S. Sagheb,et al.  Adverse events associated with neonatal exchange transfusion for hyperbilirubinemia , 2009, Indian journal of pediatrics.

[11]  N. Soni,et al.  Ten years of hemovigilance reports of transfusion‐related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma , 2009, Transfusion.

[12]  P Rouger,et al.  International Society of Blood Transfusion Committee on Terminology for Red Blood Cell Surface Antigens: Macao report , 2009, Vox sanguinis.

[13]  K. Yamaguchi,et al.  Current risks in blood transfusion in Japan. , 2008, Japanese journal of infectious diseases.

[14]  J. Sprung,et al.  Cardiac Arrests Associated with Hyperkalemia During Red Blood Cell Transfusion: A Case Series , 2008, Anesthesia and analgesia.

[15]  R. Benjamin,et al.  Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004‐2006) , 2007, Transfusion.

[16]  B. Brimhall,et al.  Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1–6°C for five days , 2006 .

[17]  S. Sanpavat.  Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital. , 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[18]  Melanie Osby,et al.  Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. , 2005, Archives of pathology & laboratory medicine.

[19]  P. Sistonen,et al.  Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens , 2004, Vox sanguinis.

[20]  B. Siner,et al.  Adverse events associated with neonatal exchange transfusion in the 1990s. , 2004, The Journal of pediatrics.

[21]  T. Dörner,et al.  Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. , 2004, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[22]  S. Urbaniak,et al.  Donor exposure rate to transfusion ratio: a better discriminator of improvement in neonatal transfusion practice , 2003, Transfusion medicine.

[23]  M. Boeckh,et al.  Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. , 2003, Blood.

[24]  P. Ljungman,et al.  Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. , 2003, Blood.

[25]  T. Mayadas,et al.  The Clearance Mechanism of Chilled Blood Platelets , 2003, Cell.

[26]  O. Castro,et al.  Predicting the effect of transfusing only phenotype‐matched RBCs to patients with sickle cell disease: theoretical and practical implications , 2002, Transfusion.

[27]  J. Menitove.  Immunoprophylaxis for D− patients receiving platelet transfusions from D−donors? , 2002 .

[28]  P. Wales,et al.  Directed blood donation in pediatric general surgery: Is it worth it? , 2001, Journal of pediatric surgery.

[29]  J M Rainey,et al.  Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  P. Mintz,et al.  The evaluation and management of platelet refractoriness and alloimmunization. , 2000, Transfusion medicine reviews.

[31]  F. Abu-Ekteish,et al.  Neonatal exchange transfusion: a Jordanian experience , 2000, Annals of tropical paediatrics.

[32]  C. Hong,et al.  Fatal hyperkalemia during rapid and massive blood transfusion in a child undergoing hip surgery--a case report. , 1999, Acta anaesthesiologica Sinica.

[33]  J. Widness,et al.  Cost‐effectiveness of a limited‐donorblood program for neonatal red cell transfusions , 1999, Transfusion.

[34]  E. Vamvakas.  Meta-analysis of randomized controlled trials of the efficacy of white cell reduction in preventing HLA-alloimmunization and refractoriness to random-donor platelet transfusions. , 1998, Transfusion medicine reviews.

[35]  T. Eastlund,et al.  Monetary blood donation incentives and the risk of transfusion‐ transmitted infection , 1998, Transfusion.

[36]  J. Jackson.  Adverse events associated with exchange transfusion in healthy and ill newborns. , 1997, Pediatrics.

[37]  Martin L. Olsson,et al.  The Blood Group Antigen Factsbook , 1997 .

[38]  E. Bell,et al.  AS‐1 red cells for neonatal transfusions: a randomized trial assessing donor exposure and safety , 1996, Transfusion.

[39]  G. Schoch,et al.  A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. , 1995, Blood.

[40]  R. Strauss,et al.  A Method to Collect, Store and Issue Multiple Aliquots of Packed Red Blood Cells for Neonatal Transfusions , 1995, Vox sanguinis.

[41]  M. Hodel,et al.  Age dependency of ABO histo‐blood group antibodies: reexamination of an old dogma , 1993, Transfusion.

[42]  R. Strauss,et al.  Commentary on the safety of red cells preserved in extended‐storage media for neonatal transfusions , 1991, Transfusion.

[43]  J. Hutton,et al.  Transfusion of ABO‐mismatched platelets leads to early platelet refractoriness , 1990, British journal of haematology.

[44]  W. Oliver,et al.  A comparison of washed red blood cells versus packed red blood cells (AS-1) for cardiopulmonary bypass prime and their effects on blood glucose concentration in children. , 1990, Anesthesiology.

[45]  A. Burks,et al.  Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. , 1986, The New England journal of medicine.

[46]  W. Keenan,et al.  Morbidity and mortality associated with exchange transfusion. , 1985, Pediatrics.

[47]  C. Bloomfield,et al.  A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. , 1981, The New England journal of medicine.

[48]  R. Aster,et al.  Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets. , 1965, Blood.

[49]  G. Bein,et al.  Transfusion-associated graft-versus-host disease. , 2009, Transfusion medicine reviews.

[50]  C. Westhoff.  The structure and function of the Rh antigen complex. , 2007, Seminars in hematology.

[51]  C. Hillyer,et al.  Handbook of pediatric transfusion medicine , 2004 .

[52]  E. Vamvakas,et al.  Determinants of the efficacy of prophylactic granulocyte transfusions: A meta‐analysis , 1997, Journal of clinical apheresis.

[53]  B. Newman,et al.  Donor reactions and injuries from whole blood donation. , 1997, Transfusion medicine reviews.

[54]  E. Rossi.  Principles of transfusion medicine , 1996 .